Connect with us

Health

University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers – GlobeNewswire

University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers First-in-class drug blocks key signals required…

Published

on

University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers

  • First-in-class drug blocks key signals required for tumour growth and metastasis
  • Highly targeted so avoids damaging healthy cells potential for improved patient outcomes
  • Modulus Oncology is currently in discussions for seed and series A investment

Sheffield, UK, 9 September 2020: Modulus Oncology, a new and rapidly emerging private biotech company focused on tr…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending